Srpski arhiv za celokupno lekarstvo 2015 Volume 143, Issue 1-2, Pages: 100-104
https://doi.org/10.2298/SARH1502100N
Full text ( 235 KB)
Cited by
Fifty years of discovery of alpha-fetoprotein as the first tumor marker
Nikulina Dina (State Medical Academy, Astrakhan, Russia)
Terentyev Alexander (N.I. Pirogov Russian National Research Medical University, Moscow, Russia)
Galimzyanov Khalil (State Medical Academy, Astrakhan, Russia)
Jurišić Vladimir (Faculty of Medical Sciences, Kragujevac)
Alpha-fetoprotein represents the most prominent oncobiomarker, widely used in
the diagnosis of hepatocellular carcinoma for monitoring of tumor
progression, presence of metastasis, assessment of cancer prognosis and
successful antitumor therapeutic measures. Yuri Semenovich Tatarinov is a
Russian scientist who first published antigen specific for human
hepatocellular carcinoma in 1963. To commemorate the 50th anniversary of the
discovery of alpha-fetoprotein, 9th International Scientific- Practical
Conference entitled “Achievements of fundamental science and translational
medicine capabilities in solving actual problems of practical public health”,
was held from May 6-8th, 2013 in Astrakhan, Russia. The conference was held
in memory of historical scientific work of Yuri Semenovich Tatarinov.
Keywords: alpha fetoprotein, first tumor marker, history of medicine, Yuri Semenovich Tatarinov
Projekat Ministarstva nauke Republike Srbije, br. 175056